Suppr超能文献

将纵隔霍奇金淋巴瘤患者的远期效应降至最低:深吸气屏气、调强放疗,还是二者联合?

Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?

作者信息

Aznar Marianne C, Maraldo Maja V, Schut Deborah A, Lundemann Michael, Brodin N Patrik, Vogelius Ivan R, Berthelsen Anne K, Specht Lena, Petersen Peter M

机构信息

Department of Oncology, Section of Radiotherapy, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Faculty of Sciences, Niels Bohr Institute, and Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

Department of Oncology, Section of Radiotherapy, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

出版信息

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):169-74. doi: 10.1016/j.ijrobp.2015.01.013. Epub 2015 Mar 5.

Abstract

PURPOSE

Hodgkin lymphoma (HL) survivors have an increased risk of cardiovascular disease (CD), lung cancer, and breast cancer. We investigated the risk for the development of CD and secondary lung, breast, and thyroid cancer after radiation therapy (RT) delivered with deep inspiration breath-hold (DIBH) compared with free-breathing (FB) using 3-dimensional conformal RT (3DCRT) and intensity modulated RT (IMRT). The aim of this study was to determine which treatment modality best reduced the combined risk of life-threatening late effects in patients with mediastinal HL.

METHODS AND MATERIALS

Twenty-two patients with early-stage mediastinal HL were eligible for the study. Treatment plans were calculated with both 3DCRT and IMRT on both DIBH and FB planning computed tomographic scans. We reported the estimated dose to the heart, lung, female breasts, and thyroid and calculated the estimated life years lost attributable to CD and to lung, breast, and thyroid cancer.

RESULTS

DIBH lowered the estimated dose to heart and lung regardless of delivery technique (P<.001). There was no significant difference between IMRT-FB and 3DCRT-DIBH in mean heart dose, heart V20Gy, and lung V20Gy. The mean breast dose was increased with IMRT regardless of breathing technique. Life years lost was lowest with DIBH and highest with FB.

CONCLUSIONS

In this cohort, 3DCRT-DIBH resulted in lower estimated doses and lower lifetime excess risks than did IMRT-FB. Combining IMRT and DIBH could be beneficial for a subgroup of patients.

摘要

目的

霍奇金淋巴瘤(HL)幸存者患心血管疾病(CD)、肺癌和乳腺癌的风险增加。我们研究了与自由呼吸(FB)相比,采用三维适形放疗(3DCRT)和调强放疗(IMRT)的深吸气屏气(DIBH)放疗后发生CD以及继发性肺癌、乳腺癌和甲状腺癌的风险。本研究的目的是确定哪种治疗方式能最大程度降低纵隔HL患者危及生命的晚期效应的综合风险。

方法和材料

22例早期纵隔HL患者符合本研究条件。在DIBH和FB计划计算机断层扫描上分别用3DCRT和IMRT计算治疗计划。我们报告了心脏、肺、女性乳房和甲状腺的估计剂量,并计算了因CD以及肺癌、乳腺癌和甲状腺癌导致的估计生命年损失。

结果

无论采用何种放疗技术,DIBH均可降低心脏和肺的估计剂量(P<0.001)。IMRT-FB和3DCRT-DIBH在平均心脏剂量、心脏V20Gy和肺V20Gy方面无显著差异。无论呼吸技术如何,IMRT均会增加平均乳房剂量。生命年损失在DIBH时最低,在FB时最高。

结论

在该队列中,与IMRT-FB相比,3DCRT-DIBH导致的估计剂量更低,终生额外风险也更低。IMRT与DIBH联合应用可能对部分患者有益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验